CopyMark Law Group
4.9/5
Drawing for RAXONE

USPTO serial 97407005

RAXONE

Reviewed by CopyMark Law Group

Reg. 7172934Status 700Registered
Filing date
Status date
Registration date
Sep 26, 2023
Examiner
PARKER, JUSTINE D
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RAXONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patrick J. Concannon

Patrick J. Concannon NUTTER, MCCLENNEN & FISH, LLPSEAPORT WEST, 155 SEAPORT BOULEVARDBOSTON, MA 02210United States

Goods and services

ClassDescriptionStatusFirst use
001chemicals used in industry and scienceACTIVE—
005pharmaceutical, veterinary and sanitary preparations, namely, chemical preparations for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory lossACTIVE—
042computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific re-search for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases, scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory lossACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 4, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 26, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 26, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 11, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 11, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 21, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 2, 2023PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 26, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 24, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 24, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 24, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 2, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2023DOCKASSIGNED TO EXAMINER—
Jun 30, 2022AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jun 30, 2022ALIEASSIGNED TO LIE—
May 17, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED—
May 17, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 16, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance